
- About WXPress
- WXPress is your window into the world of WuXi AppTec and our global partners.
- Sitemap
- Events
- Contact
- Please reach out with any business inquires.
- communications@wuxiapptec.com
July 22, 2021 ~ July 22, 2021
Dear colleagues and friends,
A global webinar titled “Fragile X Syndrome: In Pursuit of a Cure,” took place on July 22 to commemorate World Fragile X Day. This complimentary event is co-organized with FRAXA Research Foundation. We are delighted that more than 5,000 registered from more than 50 countries worldwide, coming together to raise awareness of this devastating rare disease, and to foster collaborations towards better medicines for patients.
Please click the top banner or here to enjoy the on-demand video.
At WuXi AppTec, we firmly believe in a future where “every drug can be made and every disease can be treated”. That future is only possible if we all work together.
Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec
Katie Clapp, President & Co-Founder, FRAXA Research Foundation
Katie Clapp, President & Co-Founder, FRAXA Research Foundation
Alison Singer, President, Autism Science Foundation
Wendy Bruce, Executive Director, Fragile X Association of Australia
Yinan Ma, VP, Fragile X Association of China
Karen Kelm, Board Member, Fragile X Foundation of Canada
Shalini Kedia, Chairperson, Fragile X Society – India
Sabrina Muggiati, Creator of the Eu Digo X Program – Brazil
Paula Gómez Ortega, Coordinator, Fragile X Syndrome Parent's Group – Argentina
Sandz Fraser, Coordinator, Fragile X South Africa; Owner & Trustee, FiX Africa Special Needs Homeschool
Nazhi Tabatadze, Clinic coordinator at Fragile X Center, Georgia
Andrea Lee, Executive Director, Fragile X New Zealand
Craig Erickson, Professor of Clinical Psychiatry, Cincinnati Children's Hospital and the University of Cincinnati College of Medicine
Randi Hagerman, Medical Director, MIND Institute; Distinguished Professor of Pediatrics, Endowed Chair, Fragile X Research, UC Davis Health
Elizabeth Berry-Kravis, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center
Moderator: Ted Brown, President, Fragile X Association of Australia
Neil Thompson, CSO, Healx
Mark Bear, Professor of Neuroscience, Picower Institute for Learning and Memory, MIT
Mark Gurney, Chairman & CEO, Tetra Therapeutics
Walter Kaufmann, CMO, Anavex Life Sciences; Adjunct Professor of Human Genetics, Emory University
Charles Large, CEO, Autifony Therapeutics
Moderator: Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec
Michael Tranfaglia, Medical Director & CSO, FRAXA Research Foundation
Alison Singer, President, Autism Science Foundation
Nahum Sonenberg, Professor & Gilman Cheney Chair in Biochemistry, Goodman Cancer Research Centre, McGill University
Peter Kind, Director, Simons Initiative for the Developing Brain, Patrick Wild Centre; Professor of Developmental Neuroscience, University of Edinburgh
Sumantra Chattarji, Senior Professor, National Centre for Biological Sciences, Tata Institute of Fundamental Science, Bangalore, India
Patricia Cogram, Associate Professor, Department of Genetics, IEB, Faculty of Science, University of Chile
Shangzhi Huang, Professor of Medical Genetics, Peking Union Medical College
Elizabeth Berry-Kravis, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center
Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec




























